Sign In
Buy NBIX
$165.11
+10.27 (+6.63%)
At Close: Jun 03, 2026
New Data Support The Idea That Neurocrine Biosciences Is Building A Credible Parkinson's Portfolio
01:41pm, Monday, 14'th Sep 2020
A clinical update on VY-AADC showed sustained improvements in on/off time and motor function, but the data don't support the idea that this is a truly game-changing therapy for Parkinson's.
Cramer's lightning round: 'I think you hold Boeing'
11:01pm, Thursday, 20'th Aug 2020
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
National Broadband Plan customers to get download speed boost
02:18pm, Friday, 14'th Aug 2020
Company delivering €3bn plan triples minimum download speed to 500mbps
Insider Selling: Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Sells $268,221.88 in Stock
01:54am, Tuesday, 11'th Aug 2020
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) insider Eiry Roberts sold 2,257 shares of the company’s stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $11
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) CEO Sells $403,104.90 in Stock
01:54am, Tuesday, 11'th Aug 2020
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) CEO Kevin Charles Gorman sold 3,390 shares of the firm’s stock in a transaction on Wednesday, August 5th. The shares were sold at an average price of $118.
Voyager Therapeutics Announces Second Quarter 2020 Financial Results and Corporate Updates | MarketScreener
11:01am, Monday, 10'th Aug 2020Xenon Pharmaceuticals, Inc. (XENE) CEO Simon Pimstone on Q2 2020 Results - Earnings Call Transcript
11:03am, Sunday, 09'th Aug 2020
Xenon Pharmaceuticals, Inc. (NASDAQ:XENE) Q2 2020 Earnings Conference Call August 06, 2020, 17:30 ET Company Participants Jodi Regts - VP, Corporate Affairs & IR Simon Pimstone - CEO & Directo
Fibre broadband plan includes €100 standard connection charge
08:00pm, Saturday, 08'th Aug 2020
Carrigaline townlands to be first connected to National Broadband Plan network
Dupont Capital Management Corp Purchases New Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
07:04am, Wednesday, 05'th Aug 2020
Dupont Capital Management Corp purchased a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) in the second quarter, according to the company in its most recent Form 13F filing with the Securitie
NASDAQ Rises for Fifth Straight Day and Logs Another New High
12:00am, Wednesday, 05'th Aug 2020
Stocks Analysis by Zacks Investment Research covering: McDonald’s Corporation, Neurocrine Biosciences Inc, Diebold Nixdorf Inc, Treehouse Foods Inc. Read Zacks Investment Research's latest article o
Building An Investment Portfolio: July 2020 Update And 3 Buys
10:21pm, Tuesday, 04'th Aug 2020
Don't underestimate the power of compounding of the growth stocks. The future growth may not always be priced in and may compensate even if you end up paying more.
Charting a solid August start: S&P 500, Nasdaq stage latest summer breakouts
04:38pm, Tuesday, 04'th Aug 2020
Technically speaking, the U.S. benchmarks’ bigger-picture backdrop remains bullish amid a solid August start, writes Michael Ashbaugh.
Neurocrine Biosciences Inc (NBIX) Q2 2020 Earnings Call Transcript
01:30pm, Tuesday, 04'th Aug 2020
NBIX earnings call for the period ending June 30, 2020.
